Literature DB >> 25448765

Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.

Jorge Ivan Alvarez1, Olivia Saint-Laurent2, Alisha Godschalk2, Simone Terouz2, Casper Briels2, Sandra Larouche2, Lyne Bourbonnière2, Catherine Larochelle2, Alexandre Prat2.   

Abstract

Early changes in the normal appearing white matter of multiple sclerosis (MS) patients precede the appearance of gadolinium-enhancing lesions. Although these findings suggest blood-brain barrier (BBB) breakdown as an important feature in MS pathogenesis, limited information is available on the BBB alterations during lesion genesis. Here, we perform a longitudinal characterization of the vascular, neuropathological and immunological changes before lesion formation in mice developing spontaneous relapsing-remitting experimental autoimmune encephalomyelitis (sRR-EAE). We found a significant upregulation of Th1 and Th17 cytokines in the periphery of sRR-EAE mice before any evident neuropathology. In the CNS, BBB and astroglial activations were the first pathological changes occurring after 45days of age and were followed by immune cell infiltration by day 50. These pathological alterations subsequently led to perivascular demyelination and disease onset. In MS, (p)reactive lesions mirrored the changes seen in early sRR-EAE by displaying considerable BBB disruption, perivascular astrogliosis, redistribution of junctional proteins and increased expression of endothelial cell adhesion molecules. Our findings suggest that BBB breach occurs before significant immune cell infiltration and demyelination. In addition, peripheral immune activation during sRR-EAE precedes CNS pathology, suggesting that outside in signaling mechanisms play a role in the development of neuroinflammatory lesions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (P)reactive lesion; Adherens junctions; Astrocytes; Blood–brain barrier; EAE; Lesion; Multiple sclerosis; Tight junctions

Mesh:

Year:  2014        PMID: 25448765     DOI: 10.1016/j.nbd.2014.09.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

Review 1.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

2.  Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.

Authors:  Hania Kebir; Lionel Carmant; François Fontaine; Kathie Béland; Ciprian M Bosoi; Nathalie T Sanon; Jorge I Alvarez; Sébastien Desgent; Camille L Pittet; David Hébert; Marie-Josée Langlois; Rose-Marie Rébillard; Dang K Nguyen; Cécile Cieuta-Walti; Gregory L Holmes; Howard P Goodkin; John R Mytinger; Mary B Connolly; Alexandre Prat; Elie Haddad
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

3.  Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.

Authors:  Tessa Dhaeze; Catherine Lachance; Laurence Tremblay; Camille Grasmuck; Lyne Bourbonnière; Sandra Larouche; Olivia Saint-Laurent; Marc-André Lécuyer; Rose-Marie Rébillard; Stephanie Zandee; Alexandre Prat
Journal:  JCI Insight       Date:  2019-03-21

Review 4.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

5.  Mechanical disruption of the blood-brain barrier following experimental concussion.

Authors:  Victoria E Johnson; Maura T Weber; Rui Xiao; D Kacy Cullen; David F Meaney; William Stewart; Douglas H Smith
Journal:  Acta Neuropathol       Date:  2018-02-19       Impact factor: 17.088

6.  The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction.

Authors:  Vanessa Coelho-Santos; Ricardo A Leitão; Filipa L Cardoso; Inês Palmela; Manuel Rito; Marcos Barbosa; Maria A Brito; Carlos A Fontes-Ribeiro; Ana P Silva
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-22       Impact factor: 6.200

7.  Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.

Authors:  Nathanael J Lee; Seung-Kwon Ha; Pascal Sati; Martina Absinta; Nicholas J Luciano; Jennifer A Lefeuvre; Matthew K Schindler; Emily C Leibovitch; Jae Kyu Ryu; Mark A Petersen; Afonso C Silva; Steven Jacobson; Katerina Akassoglou; Daniel S Reich
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

8.  Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Authors:  Sarah E Lutz; Julian R Smith; Dae Hwan Kim; Carl V L Olson; Kyle Ellefsen; Jennifer M Bates; Sunil P Gandhi; Dritan Agalliu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

Review 9.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

Review 10.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.